Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: Effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase

Carcinogenesis

Volumn 25, Issue 9, 2004, Pages 1671-1679

  Hong, Jungil ^a   Bose, Mousumi ^a   Ju, Jihyeung ^a   Ryu, Jae Ha ^a   Chen, Xiaoxin ^a   Sang, Shengmin ^a   Lee, Mao Jung ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIBENZOYLMETHANE DERIVATIVE; LIPOPOLYSACCHARIDE; PEROXIDASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TETRAHYDROCURCUMIN; TRIMETHOXYDIBENZOYLMETHANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BENZOATES; CELLS, CULTURED; CHALCONES; COLONIC NEOPLASMS; CURCUMIN; CYTOSOL; DINOPROSTONE; ENZYME INHIBITORS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SHEEP;

EID: 4544236324     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh165     Document Type: Article

References (44)

1. Ammon,H.P. and Wahl,M.A. (1991) Pharmacology of Curcuma longa. Planta Med., 57, 1-7.
2. Huang,M.T., Lou,Y.R., Ma,W., Newmark,H.L., Reuhl,K.R. and Conney,A.H. (1994) Inhibitory effects of dietary curcumin on fore-stomach, duodenal and colon carcinogenesis in mice. Cancer Res., 54, 5841-5847.
3. Huang,M.T., Smart,R.C., Wong,C.Q. and Conney,A.H. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbot-13-acetate. Cancer Res., 48, 5941-5946.
4. Chuang,S.E., Kuo,M.L., Hsu,C.H., Chen,C.R., Lin,J.K., Lai,G.M., Hsieh,C.Y. and Cheng,A.L. (2000) Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis, 21, 331-335.
5. Ushida,J., Sugie,S., Kawabata,K., Pham,Q.V., Tanaka,T., Fujii,K., Takeuchi,H., Ito,Y. and Mori,H. (2000) Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res., 91, 893-898.
6. Inano,H., Onoda,M., Inafuku,N., Kubota,M., Kamada,Y., Osawa,T., Kobayashi,H. and Wakabayashi,K. (1999) Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis, 20, 1011-1018.
7. Li,N., Chen,X., Liao,J., Yang,G., Wang,S., Josephson,Y., Han,C., Chen,J., Huang,M.T. and Yang,C.S. (2002) Inhibition of 7,12-dimethylbenz[a] anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis, 23, 1307-1313.
8. Huang,T.S., Lee,S.C. and Lin,J.K. (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl Acad. Sci. USA, 88, 5292-5296.
9. Plummer,S.M., Holloway,K.A., Manson,M.M., Munks,R.J., Kaptein,A., Farrow,S. and Howells,L. (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene, 18, 6013-6020.
10. Arbiser,J.L., Klauber,N., Rohan,R., van Leeuwen,R., Huang,M.T., Fisher,C., Flynn,E. and Byers,H.R. (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med., 4, 376-383.
11. Mohan,R., Sivak,J., Ashton,P., Russo,L.A., Pham,B.Q., Kasahara,N., Raizman,M.B. and Fini,M.E. (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem., 275, 10405-10412.
12. NCI (1996) Clinical development plan: curcumin. J. Cell Biochem. Suppl., 26, 72-85.
13. Lin,C.C., Lu,Y.P., Lou,Y.R., Ho,C.T., Newmark,H.H., MacDonald,C., Singletary,K.W. and Huang,M.T. (2001) Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands and mammary tumorigenesis in Sencar mice. Cancer Lett., 168, 125-132.
14. Cuendet,M. and Pezzuto,J.M. (2000) The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact., 17, 109-157.
15. Huang,M.T., Newmark,H.L. and Frenkel,K. (1997) Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl., 27, 26-34.
16. Conney,A.H., Lysz,T., Ferraro,T., Abidi,T.F., Manchand,P.S., Laskin,J.D. and Huang,M.T. (1991) Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul., 31, 385-396.
17. Goel,A., Boland,C.R. and Chauhan,D.P. (2001) Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett., 172, 111-118.
18. Zhang,F., Altorki,N.K., Mestre,J.R., Subbaramaiah,K. and Dannenberg,A.J. (1999) Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 20, 445-451.
19. Chun,K.S., Keum,Y.S., Han,S.S., Song,Y.S., Kim,S.H. and Surh,Y.J. (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation. Carcinogenesis, 24, 1515-1524.
20. Huang,M.T., Lysz,T., Ferraro,T., Abidi,T.F., Laskin,J.D. and Conney,A.H. (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res., 51, 813-819.
21. Rao,C.V., Rivenson,A., Simi,B. and Reddy,B.S. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 55, 259-266.
22. Dole,V.P. and Meinertz,H. (1960) Microdetermination of long-chain fatty acid in plasma and tissues. J. Biol. Chem., 235, 2595-2599.
23. Hong,J., Smith.,T.J., Ho,C.T., August,D.A. and Yang,C.S. (2001) Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem. Pharmacol., 62, 1175-1183.
24. Gierse,J.K. and Koboldt,C.M. (1998) Cyclooxygenase assays. In Enna,S.J., Williams,M., Ferkany,J.W., Kenakin,T., Porsolt,R.D. and Sullivan,J.P. (eds) Current Protocols in Pharmacology. John Wiley & Sons, Inc., New York, vol. 1, pp. 3.1.1-16.
25. 2. J. Biol. Chem., 272, 16709-16712.
26. Romano,M. and Claria,J. (2003) Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J., 17, 1986-1995.
27. Steele,V.E., Holmes,C.A., Hawk,E.T., Kopelovich,L., Lubet,R.A., Crowell,J.A., Sigman,C.C. and Kelloff,G.J. (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev., 8, 467-483.
28. Subbaramaiah,K., Zakim,D., Weksler,B.B. and Dannenberg,A.J. (1997) Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 201-210.
29. 2. Biochim. Biophys. Acta, 1488, 124-138.
30. Geppert,T.D., Whitehurst,C.E., Thompson,P. and Beutler,B. (1994) Lipopolysaccharide, signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol. Med., 1, 93-103.
31. Hambleton,J., Weinstein,S.L., Lem,L. and DeFranco,A.L. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl Acad. Sci. USA, 93, 2774-2778.
32. Schafer,P.H., Wang,L., Wadsworth,S.A., Davis,J.E. and Siekierka,J.J. (1999) T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes. J. Immunol., 162, 659-668.
33. 2 is phosphorylated and activated by MAP kinase. Cell, 72, 269-278.
34. 2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem., 271, 27723-27729.
35. 2. Biochem. J., 308 (Pt 3), 815-822.
36. 2 activation. J. Leukoc. Biol., 65, 330-336.
37. Chen,Y.R. and Tan,T.H. (1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene, 17, 173-178.
38. Jobin,C., Bradham,C.A., Russo,M.P., Juma,B., Narula,A.S., Brenner,D.A. and Sartor,R.B. (1999) Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J. Immunol., 163, 3474-3483.
39. Ghosh,J. and Myers,C.E. (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl Acad. Sci. USA, 95, 13182-13187.
40. Ghosh,J. and Myers,C.E. (1997) Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun., 235, 418-423.
41. Skrzypczak-Jankun,E., McCabe,N.P., Selman,S.H. and Jankun,J. (2000) Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. Int. J. Mol. Med., 6, 521-526.
42. Began,G., Sudharshan,E. and Appu Rao,A.G. (1998) Inhibition of lipoxygenase-1 by phosphatidylcholine micelles-bound curcumin. Lipids, 33, 1223-1228.
43. Fiorucci,S., Meli,R., Bucci,M. and Cirino,G. (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem. Pharmacol., 62, 1433-1438.
44. Leval,X., Julemont,F., Delarge,J., Pirotte,B. and Dogne,J.M. (2002) New trends in dual 5-LOX/COX inhibition. Curr. Med. Chem., 9, 941-962.